Survival rate for PAM in Kerala improved to about 24%, higher than global rate below 3% Miltefosine used early with other drugs and supportive care in Kerala’s PAM treatment Miltefosine dosing in Kerala follows US CDC guidelines: typically 50 mg thrice daily for adults
